TRIM72 and neoplasm: Mechanistically, LINC01852 functioned as a molecular scaffold to enhance the interaction of TRIM72 with SRSF5 and facilitate TRIM72-mediated degradation of SRSF5, thus inhibiting aerobic glycolysis, tumor growth and chemoresistance.